OEM Partnership Focus Evergen operates as a leading CDMO partnering with OEMs to identify clinical problems and develop customized regenerative medicine solutions, backed by an extensive portfolio of biological materials. With emphasis on plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neurosurgery, there are clear sales opportunities to engage OEMs in these segments to co-develop and manufacture tissue-engineered products.

AI Imaging Collaboration The February 2025 partnership with the University of Florida to launch AI-powered bone graft image processing software demonstrates a capability to integrate advanced analytics with regenerative products. This opens a path to sell imaging analytics to hospitals, academic medical centers, and orthopedic networks, with potential upsell through ongoing services and scalable data platforms leveraging Azure Machine Learning and Python.

Regenerative Medicine Focus Evergen’s specialization in regenerative solutions across multiple clinical domains provides a multi-vertical sales angle. Tailor value propositions around accelerated healing, reduced complications, and customized biomaterials, while offering end-to-end CDMO services, regulatory support, and scalable manufacturing for tissue-engineered therapies.

Credibility & Awards Being named Best Overall MedTech Company at the MedTech Breakthrough Awards enhances credibility in outreach to potential customers and OEM partners. Leverage this recognition in conversations and proposals to differentiate Evergen and support faster partnerships and procurement decisions.

Growth & Capabilities With revenue in the reported range of one hundred to two hundred fifty million dollars and a workforce of five hundred to one thousand, Evergen has the scale to support sizable manufacturing partnerships. Highlight the tech stack—Azure Machine Learning, Python, continuous delivery—and data-driven manufacturing capabilities to reassure prospects about quality, regulatory compliance, and reliable supply chains.